Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience

被引:8
|
作者
Crepinsek, Klementina [1 ,2 ]
Marinsek, Gasper [1 ]
Kavcic, Marko [2 ,3 ]
Prelog, Tomaz [3 ]
Kitanovski, Lidija [3 ]
Jazbec, Janez [2 ,3 ]
Debeljak, Marusa [1 ,2 ]
机构
[1] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Clin Inst Special Lab Diagnost, Vrazov Trg 1, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[3] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Dept Oncol & Haematol, Ljubljana, Slovenia
关键词
B-acute lymphoblastic leukemia; IKZF1; deletions; IKZF1(plus); MLPA; pediatric; copy number variations (CNVs); IKZF1; DELETION; IKAROS GENE; PROGNOSTIC MARKER; POOR-PROGNOSIS; PRECURSOR; CHILDHOOD; CHILDREN; PAX5; STRATIFICATION; CLASSIFICATION;
D O I
10.2478/raon-2021-0050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background IKZF1 gene deletions have been identified as a poor prognostic factor in pediatric B-cell acute lymphoblastic leukemia (B-ALL), especially in the presence of co-occurring deletions (IKZF1(plus) profile). This study aimed to determine the frequency of IKZF1 deletions and deletions in other B-cell differentiation and cell cycle control genes, and their prognostic impact in Slovenian pediatric B-ALL patients. Patients and methods We studied a cohort of 99 patients diagnosed with B-ALL from January 2012 to December 2020 and treated according to the ALL IC-BFM 2009 protocol. Eighty-eight bone marrow or peripheral blood samples were analysed for copy number variations (CNVs) using the SALSA MLPA P335 ALL-IKZF1 probemix. Results At least one CNV was detected in more than 65% of analysed samples. The most frequently altered genes were PAX5 and CDKN2A/B (30.7%, 26.1%, and 25.0%, respectively). Deletions in IKZF1 were present in 18.2% of analysed samples and were associated with an inferior 5-year event-free survival (EFS; 54.8% vs. 85.9%, p = 0.016). The IKZF1(plus) profile was identified in 12.5% of the analysed samples, and these patients had an inferior 5-year EFS than those with deletions in IKZF1 only and those without deletions (50.8% vs. 75.0% vs. 85.9%, respectively, p = 0.049). Overall survival (OS) was also worse in patients with the IKZF1(plus) profile than those with deletions in IKZF1 only and those without deletions (5-year OS 76.2% vs. 100% vs. 93.0%, respectively). However, the difference between the groups was not statistically significant. Conclusions Our results are in concordance with the results obtained in larger cooperative clinical trials. Copy number variations analysis using the SALSA MLPA kit is a reliable tool for initial diagnostic approach in children with B-ALL, even in smaller institutions in low- and middle-income countries.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 50 条
  • [21] Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
    Liu, Yuan-Fang
    Wang, Bai-Yan
    Zhang, Wei-Na
    Huang, Jin-Yan
    Li, Ben-Shang
    Zhang, Ming
    Jiang, Lu
    Li, Jian-Feng
    Wang, Ming-Jie
    Dai, Yu-Jun
    Zhang, Zi-Guan
    Wang, Qiang
    Kong, Jie
    Chen, Bing
    Zhu, Yong-Mei
    Weng, Xiang-Qin
    Shen, Zhi-Xiang
    Li, Jun-Min
    Wang, Jin
    Yan, Xiao-Jing
    Li, Yan
    Liang, Ying-Min
    Liu, Li
    Chen, Xie-Qun
    Zhang, Wang-Gang
    Yan, Jin-Song
    Hu, Jian-Da
    Shen, Shu-Hong
    Chen, Jing
    Gu, Long-Jun
    Pei, Deqing
    Li, Yongjin
    Wu, Gang
    Zhou, Xin
    Ren, Rui-Bao
    Cheng, Cheng
    Yang, Jun J.
    Wang, Kan-Kan
    Wang, Sheng-Yue
    Zhang, Jinghui
    Mi, Jian-Qing
    Pui, Ching-Hon
    Tang, Jing-Yan
    Chen, Zhu
    Chen, Sai-Juan
    EBIOMEDICINE, 2016, 8 : 173 - 183
  • [22] Preclinical and Clinical Evaluation of Forodesine in Pediatric and Adult B-Cell Acute Lymphoblastic Leukemia
    Balakrishnan, Kumudha
    Ravandi, Farhad
    Bantia, Shanta
    Franklin, Anna
    Gandhi, Varsha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 458 - 466
  • [23] Inotuzumab Use: A Single-Center Experience in B-Cell Acute Lymphoblastic Leukemia
    Espinoza, Marcela
    Rojas, Jorge
    Lopez-Vidal, Hernan
    Jose Castaneda, Andres
    Tomas Gazmuri, Jose
    BLOOD, 2023, 142
  • [24] Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia
    Tsao, L
    Draoua, HY
    Osunkwo, I
    Nandula, SV
    Murty, VVS
    Mansukhani, M
    Bhagat, G
    Alobeid, B
    MODERN PATHOLOGY, 2004, 17 (07) : 832 - 839
  • [25] The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia
    Urbanska, Zuzanna
    Lejman, Monika
    Taha, Joanna
    Madzio, Joanna
    Ostrowska, Kinga
    Miarka-Walczyk, Karolina
    Wypyszczak, Kamila
    Styka, Borys
    Jakubowska, Justyna
    Sedek, Lukasz
    Szczepanski, Tomasz
    Stanczak, Marcin
    Fendler, Wojciech
    Mlynarski, Wojciech
    Pastorczak, Agata
    NEOPLASIA, 2023, 35
  • [26] Aberrant splicing in B-cell acute lymphoblastic leukemia
    Black, Kathryn L.
    Naqvi, Ammar S.
    Asnani, Mukta
    Hayer, Katharina E.
    Yang, Scarlett Y.
    Gillespie, Elisabeth
    Bagashev, Asen
    Pillai, Vinodh
    Tasian, Sarah K.
    Gazzara, Matthew R.
    Carroll, Martin
    Taylor, Deanne
    Lynch, Kristen W.
    Barash, Yoseph
    Thomas-Tikhonenko, Andrei
    NUCLEIC ACIDS RESEARCH, 2018, 46 (21) : 11357 - 11369
  • [27] Case Report on Acute Lymphoblastic Leukemia B-Cell
    Sakharwade, Prerana
    Watmode, Ankita
    Kurian, Bibin
    Meshram, Khushbu
    Kolhekar, Sonali
    Sawarkar, Achita
    Shambharkar, Madhuri
    Tembhare, Vaishali
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (49B) : 39 - 44
  • [28] B-CELL MARKERS ON LYMPHOBLASTS IN ACUTE LYMPHOBLASTIC LEUKEMIA
    GAJLPECZALSKA, KJ
    BLOOMFIELD, CD
    NESBIT, ME
    KERSEY, JH
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1974, 17 (04): : 561 - 569
  • [29] Ocular Relapse of B-Cell Acute Lymphoblastic Leukemia
    Ferenchak, Kevin
    Dao, Linda N.
    Dalvin, Lauren A.
    JAMA OPHTHALMOLOGY, 2021, 139 (04)
  • [30] Obecabtagene Autoleucel for B-Cell Acute Lymphoblastic Leukemia
    Bouchkouj, Najat
    Przepiorka, Donna
    Fashoyin-Aje, Lola A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,